www.fdanews.com/articles/96489-ev3-receives-ce-mark-approval-for-the-axium-detachable-coil-system
ev3 Receives CE Mark Approval for the Axium Detachable Coil System
July 30, 2007
ev3 Inc. has announced that it received CE Mark approval for its Axium Detachable Coil System (“Axium”). Axium was approved for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. It is also intended for use in the European Union for the treatment of peripheral vascular abnormalities.
Business Wire